ArticleTheranostics2026

A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis.

Dingyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.